Levels of drug and antidrug antibodies are associated with outcome of interventions after loss of response to infliximab or adalimumab

MLA

Yehuda Chowers, et al. “Levels of Drug and Antidrug Antibodies Are Associated with Outcome of Interventions after Loss of Response to Infliximab or Adalimumab.” Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association, vol. 13, no. 3, Mar. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....dc0331fffed6461dd7e11b68f3a24c5c&authtype=sso&custid=ns315887.

APA

Yehuda Chowers, Iris Dotan, Gerald Fraser, Arie Levine, Raanan Shamir, Yoav Mazor, Batia Weiss, Yulia Ron, Shomron Ben-Horin, Henit Yanai, Lev Lichtenstein, Amit Assa, Yoram Bujanover, Yoram Rosenbach, Bella Ungar, Uri Kopylov, & Rami Eliakim. (2014). Levels of drug and antidrug antibodies are associated with outcome of interventions after loss of response to infliximab or adalimumab. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association, 13(3).

Chicago

Yehuda Chowers, Iris Dotan, Gerald Fraser, Arie Levine, Raanan Shamir, Yoav Mazor, Batia Weiss, et al. 2014. “Levels of Drug and Antidrug Antibodies Are Associated with Outcome of Interventions after Loss of Response to Infliximab or Adalimumab.” Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 13 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....dc0331fffed6461dd7e11b68f3a24c5c&authtype=sso&custid=ns315887.